The human ether-à-go-go related gene (hERG) inhibition at 10uM of a drug with the SMILES COC(=O)[C@@]12CCCCN1[C@H](c1ccc(-c3ccc(F)cc3)c(OC)c1)[C@@H]1C(=O)N(C)C(=O)[C@@H]12.O=C(O)C(F)(F)F is -3.448%.
The {herg_central_at_10uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_10uM#}{herg_central_at_10uM__units}.
COC(=O)[C@@]12CCCCN1[C@H](c1ccc(-c3ccc(F)cc3)c(OC)c1)[C@@H]1C(=O)N(C)C(=O)[C@@H]12.O=C(O)C(F)(F)F
COC(=O)[C@@]12CCCCN1[C@H](c1ccc(-c3ccc(F)cc3)c(OC)c1)[C@@H]1C(=O)N(C)C(=O)[C@@H]12.O=C(O)C(F)(F)F
methyl (3aR,4S,9aS,9bS)-4-[4-(4-fluorophenyl)-3-methoxyphenyl]-2-methyl-1,3-dioxo-4,6,7,8,9,9b-hexahydro-3aH-pyrrolo[3,4-a]indolizine-9a-carboxylate;2,2,2-trifluoroacetic acid